ABEO ABEONA THERAPEUTICS INC Contract Awards 8-K Filing 2024 - FDA Application Resubmission Abeona Therapeutics Inc. announced the completion of its resubmission of the Pz-cel Biologics License Application to the U.S. FDA on October 29, 2024.Get access to all SEC 8-K filings of the ABEONA THERAPEUTICS INC